Literature DB >> 25023703

Conditional inactivation of the mouse von Hippel-Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney.

T L Pritchett1, H L Bader1, J Henderson2, T Hsu3.   

Abstract

Mutations of the tumor suppressor gene von Hippel-Lindau (VHL) can lead to benign and malignant tumors, including clear-cell renal cell carcinoma (ccRCC). To understand the progression of ccRCC, we generated a novel mouse Vhlh conditional knockout, using Hoxb7-driven Cre that is specific for the collecting ducts and a subset of distal tubules. These mice exhibited wide-spread epithelial disruption and interstitial inflammation as early as 2 months of age with high penetrance. Lesions are cystic, show severe fibrosis and display significant hyperplasia. An abundance of infiltrating macrophages and lymphocytes was detected. Interestingly, the Vhlh mutant lesions could be rescued when Hif-1α, but not Hif-2α, was also knocked out. In addition, administration of a JAK1/2 kinase inhibitor alleviated the Vhlh knockout phenotypes. Taken together, these results suggest that HIF-1α-dependent inflammation and fibrosis may be an early event in the development of ccRCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023703     DOI: 10.1038/onc.2014.197

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

Review 1.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

2.  The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.

Authors:  Yarong Guo; Xiaojiang Qin; Bao Chai; Junmei Jia; Jiahong Yi; Kang Wang; Xiaomin Hou
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Disruption of tubular Flcn expression as a mouse model for renal tumor induction.

Authors:  Jindong Chen; Dachuan Huang; Isabelle Rubera; Kunihiko Futami; Pengfei Wang; Peter Zickert; Sok-Kean Khoo; Karl Dykema; Ping Zhao; David Petillo; Brian Cao; Zhongfa Zhang; Shuhui Si; Susan R Schoen; Ximing J Yang; Ming Zhou; Guang-Qian Xiao; Guan Wu; Magnus Nordenskjöld; Michel Tauc; Bart O Williams; Kyle A Furge; Bin Tean Teh
Journal:  Kidney Int       Date:  2015-06-17       Impact factor: 10.612

4.  Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).

Authors:  Johannes C van der Mijn; Qiuying Chen; Kristian B Laursen; Francesca Khani; Xiaofei Wang; Princesca Dorsaint; Andrea Sboner; Steven S Gross; David M Nanus; Lorraine J Gudas
Journal:  Mol Carcinog       Date:  2022-06-21       Impact factor: 5.139

Review 5.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

6.  DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.

Authors:  Yu-Ting Chang; Ching-Chin Yang; Szu-Yu Pan; Yu-Hsiang Chou; Fan-Chi Chang; Chun-Fu Lai; Ming-Hsuan Tsai; Huan-Lun Hsu; Ching-Hung Lin; Wen-Chih Chiang; Ming-Shiou Wu; Tzong-Shinn Chu; Yung-Ming Chen; Shuei-Liong Lin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

7.  CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma.

Authors:  Shiruyeh Schokrpur; Junhui Hu; Diana L Moughon; Peijun Liu; Lucia C Lin; Kip Hermann; Serghei Mangul; Wei Guan; Matteo Pellegrini; Hua Xu; Lily Wu
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

8.  Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model.

Authors:  Hannah L Bader; Tien Hsu
Journal:  BMC Cancer       Date:  2016-10-12       Impact factor: 4.430

9.  Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.

Authors:  Jizhou Wang; Zhaoyang Lu; Zhilin Xu; Pei Tian; Hui Miao; Shangha Pan; Ruipeng Song; Xueying Sun; Baolei Zhao; Dawei Wang; Yong Ma; Xuan Song; Shugeng Zhang; Lianxin Liu; Hongchi Jiang
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

10.  Loss of Function of von Hippel-Lindau Trigger Lipocalin 2-Dependent Inflammatory Responses in Cultured and Primary Renal Tubular Cells.

Authors:  Chan-Yen Kuo; Valeria Chiu; Po-Chun Hsieh; Tien Hsu; Ting-Yun Lin
Journal:  Oxid Med Cell Longev       Date:  2021-06-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.